— Know what they know.
Not Investment Advice

ORGO NASDAQ

Organogenesis Holdings Inc.
1W: -5.7% 1M: -20.4% 3M: -46.4% YTD: -71.3% 1Y: -69.0% 3Y: -58.2% 5Y: -91.1%
$1.33
-0.07 (-5.00%)
 
Weekly Expected Move ±7.1%
$1 $1 $1 $1 $2
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 31 · $171.1M mcap · 57M float · 1.38% daily turnover · Short 64% of daily vol

Balance Sheet Trends

Total Assets
$599M +20.3% ▲
5Y CAGR: +15.6%
Total Liabilities
$165M +46.4% ▲
5Y CAGR: +2.1%
Shareholders Equity
$434M +12.6% ▲
5Y CAGR: +25.1%
Cash & Investments
$94M -30.9% ▼
5Y CAGR: +2.1%
Total Debt
$133M +206.7% ▲
5Y CAGR: +9.4%
Net Debt
$39M +142.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$114M$102M$104M$136M$94M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$114M$102M$104M$136M$94M
Net Receivables$82M$89M$82M$110M$217M
Inventory$25M$25M$28M$26M$30M
Other Current Assets$711K$5M$1M$6M$21M
Total Current Assets$227M$223M$225M$286M$362M
Property, Plant & Equip.$128M$146M$156M$126M$159M
Goodwill & Intangibles$54M$50M$45M$41M$38M
Long-Term Investments$0$0$16M$0$0
Other Non-Current Assets$2M$2M-$10M$5M$9M
Total Non-Current Assets$216M$227M$235M$212M$237M
Total Assets$443M$449M$460M$498M$599M
— Liabilities —
Accounts Payable$29M$32M$31M$29M$32M
Short-Term Debt$3M$5M$5M$0$19M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$29M$9M$22M$25M$50M
Total Current Liabilities$83M$75M$81M$77M$100M
Long-Term Debt$71M$66M$61M$0$51M
Other Non-Current Liab.$2M$1M$1M$894K-$50M
Total Non-Current Liabilities$119M$109M$101M$35M$65M
Total Liabilities$202M$184M$181M$113M$165M
— Equity —
Common Stock$13K$13K$13K$13K$13K
Retained Earnings-$61M-$45M-$41M-$40M-$3M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$241M$266M$279M$385M$434M
Total Liabilities & Equity$443M$449M$460M$498M$599M
— Key Metrics —
Total Debt$132M$124M$119M$43M$133M
Net Debt$18M$21M$15M-$92M$39M
Total Investments$0$0$16M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms